Skip to content
healthcare.dev

Vardenafil Hydrochloride

NDC 71610-508, Vardenafil Hydrochloride, tablet, from Aphena Pharma Solutions - Tennessee, LLC.

Product NDC
71610-508
Status
Listed
Labeler
Aphena Pharma Solutions - Tennessee, LLC
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA209057
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/71610-508 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • VARDENAFIL HYDROCHLORIDE20 mg/1

Pharmacologic classes

Phosphodiesterase 5 Inhibitor [EPC]; Phosphodiesterase 5 Inhibitors [MoA]

Package NDCNDC-11Package
71610-508-02716100508022 TABLET in 1 BOTTLE (71610-508-02)
71610-508-04716100508044 TABLET in 1 BOTTLE (71610-508-04)
71610-508-127161005081212 TABLET in 1 BOTTLE (71610-508-12)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/09366eb3-93e0-41d9-bf9a-24335ed3555f

Use it

Look up 71610-508 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/71610-508 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 71610-508. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.